![](/img/cover-not-exists.png)
PD-033Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy
Ostrizkova, L., Petruželka, L., Hejduk, K., Zdražilová-Dubská, L., Vocka, M., Brancikova, D., Bencsiková, B., Vyzula, R., Obermannová, R.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw200.33
Date:
June, 2016
File:
PDF, 66 KB
2016